An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
- 1 February 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (2) , 120-127
- https://doi.org/10.1001/archpsyc.1988.01800260024003
Abstract
• Isocarboxazid and placebo were evaluated in 130 anxious depressives. Drug was superior to placebo on depression, anxiety, interpersonal sensitivity, and global measures, and on symptoms of hostility, anxiety, obsessiveness, and psychological-cognitive components of depression. There were no significant differences between treatment effects on psychomotor and typical vegetative symptoms. Isocarboxazid was more effective than placebo in major, but not in minor, depression. It was significantly more effective in depression classified as endogenous depression or melancholia by various diagnostic criteria. Drug was more effective than placebo in atypical depression with vegetative reversal and in Brief Psychiatric Rating Scale (BPRS)—derived profiles of anxious and hostile depression; there were no drug-placebo differences in atypical depression without vegetative reversal, or in BPRS retarded and agitated/excited depression. Interpersonal sensitivity emerged as an important drug-responsive dimension.This publication has 36 references indexed in Scilit:
- Isocarboxazid in the treatment of depressionAmerican Journal of Psychiatry, 1983
- Response to Phenelzine and Amitriptyline in Subtypes of Outpatient DepressionArchives of General Psychiatry, 1982
- Monoamine oxidase inhibitor-responsive depressionPsychiatry Research, 1982
- Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal SymptomsArchives of General Psychiatry, 1980
- Monoamine oxidase inhibitors: a personal accountPublished by Elsevier ,1977
- Towards Rational Therapy with Monoamine Oxidase InhibitorsThe British Journal of Psychiatry, 1976
- A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety StatesArchives of General Psychiatry, 1976
- The Monoamine Oxidase Inhibitor, Phenelzine, in the Treatment of Depressive-Anxiety StatesArchives of General Psychiatry, 1973
- A Double-Blind Trial of Phenelzine and Amitriptyline in Depressed Out-Patients. a Possible Differential Effect of the Drugs on SymptomsThe British Journal of Psychiatry, 1973
- Phenelzine in phobic anxiety: a controlled trialPsychological Medicine, 1973